Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model
- 30 June 1996
- journal article
- Published by Elsevier in Surgical Oncology
- Vol. 5 (3) , 141-147
- https://doi.org/10.1016/s0960-7404(96)80014-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Pyridinium crosslinks as markers of bone resorption in patients with breast cancerBritish Journal of Cancer, 1991
- Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseaseBone and Mineral, 1990
- Protective Effects of a Prophylactic Treatment with the Bisphosphonate 3-Amino-1 -Hydroxypropane-1,1 -Bisphosphonic Acid on the Development of Tumor Osteopathies in the Rat: Experimental Studies with the Walker Carcinosarcoma 256Oncology, 1988
- A model of localized osteolysis induced by the MBT-2 tumor in mice and its responsiveness to etidronate disodiumZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- The clinical course of bone metastases from breast cancerBritish Journal of Cancer, 1987
- Effects of new bisphosphonic acids on tumor-induced bone destruction in the ratZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Bisphosphonates and bone resorption: Effects on collagenase and lysosomal enzyme ezcretionLife Sciences, 1985
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- Mechanisms of bone destruction in the development of skeletal metastasesNature, 1976
- Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandinsNature, 1976